Horm Metab Res 1984; 16(12): 667-670
DOI: 10.1055/s-2007-1014878
Clinical

© Georg Thieme Verlag, Stuttgart · New York

Urinary 3-Methylhistidine Derivative as Indicator of Nutrients Intake in Low-Birth-Weight Infants

A. Gil1 , M. J. Faus2 , R. Robles3 , M. L. Pita2 , A. Sánchez-Pozo2 , M. D. Linares3 , F. Sánchez-Medina2
  • 1Research Department of UNIASA-EDDA, Granada, Spain
  • 2Department of Biochemistry of the University of Granada, Granda, Spain
  • 3Neonatology Section of “Virgen de las Nieves” Hospital, Granada, Spain
Further Information

Publication History

1983

1983

Publication Date:
14 March 2008 (online)

Summary

Urinary excretion levels of N-methylhistidine derivatives and N-methylhistidine/creatinine ratios were studied in a group of 20 small for date newborns, 10 premature infants and 8 normal infants, at birth and at one week of life. All infants were fed with an adapted milk formula supplying 2.8 g protein/kg body weight. 1-methyl and 3-methylhistidine urinary excretion were increased in all groups of infants from birth to the 7th day of life. Creatinine and N-methyl derivatives/creatinine ratios were also significantly increased at one week of life. The two ratios showed a higher level in small for date and premature infants than in normal infants at birth which continued relatively increased at one week of life. 3-methylhistidine/creatinine ratio appears as a useful indicator of the turnover rate of muscular proteins in low-birth-weight infants.